CASC15 was firstly identified as a pivotal tumor suppressor in neuroblastoma but was later reported to play an oncogenic role in many other cancer types, such as melanoma, gastric cancer, liver cancer, lung cancer, and acute leukemia [21, 22, 27–29, 39, 40]. Here, CASC15 is linked to lung cancer.